Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Robinan Gentry

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Regulatory Toxicology and Pharmacology : RTP|November 22, 2017
Six years after the NRC review of EPA's Draft IRIS Toxicological Review of Formaldehyde: Regulatory implications of new science in evaluating formaldehyde leukemogenicityKenneth A Mundt, P Robinan Gentry, Linda D Dell, et al.
Regulatory Toxicology and Pharmacology : RTP|February 2, 2019
An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking waterHarvey J Clewell, P Robinan Gentry, C Eric Hack, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 2, 2004
Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetryHarvey J Clewell, P Robinan Gentry, Tammie R Covington, et al.
ALTEX|May 28, 2025
Evaluation of a high-throughput in-vitro-to-in-vivo extrapolation (IVIVE) workflow for the prioritization of potential developmental toxicity of chemicalsMatthew W Linakis, Rebecca A Clewell, Jerry Campbell, et al.
Inhalation Toxicology|August 21, 2003
Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vaporsRamesh Sarangapani, P Robinan Gentry, Tammie R Covington, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 17, 2019
Extended Analysis and Evidence Integration of Chloroprene as a Human CarcinogenSonja N Sax, P Robinan Gentry, Cynthia Van Landingham, et al.
Regulatory Toxicology and Pharmacology : RTP|February 19, 2014
The impact of recent advances in research on arsenic cancer risk assessmentP Robinan Gentry, Harvey J Clewell, Tracy B Greene, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Physiologically based pharmacokinetic/toxicokinetic modelingJerry L Campbell, Rebecca A Clewell, P Robinan Gentry, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 30, 2019
Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk AssessmentHarvey Checkoway, Peter S J Lees, Linda D Dell, et al.
Critical Reviews in Toxicology|August 16, 2011
Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalateP Robinan Gentry, Harvey J Clewell, Rebecca Clewell, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Regulatory Toxicology and Pharmacology : RTP|November 22, 2017
Six years after the NRC review of EPA's Draft IRIS Toxicological Review of Formaldehyde: Regulatory implications of new science in evaluating formaldehyde leukemogenicityKenneth A Mundt, P Robinan Gentry, Linda D Dell, et al.
Regulatory Toxicology and Pharmacology : RTP|February 2, 2019
An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking waterHarvey J Clewell, P Robinan Gentry, C Eric Hack, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 2, 2004
Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetryHarvey J Clewell, P Robinan Gentry, Tammie R Covington, et al.
ALTEX|May 28, 2025
Evaluation of a high-throughput in-vitro-to-in-vivo extrapolation (IVIVE) workflow for the prioritization of potential developmental toxicity of chemicalsMatthew W Linakis, Rebecca A Clewell, Jerry Campbell, et al.
Inhalation Toxicology|August 21, 2003
Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vaporsRamesh Sarangapani, P Robinan Gentry, Tammie R Covington, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 17, 2019
Extended Analysis and Evidence Integration of Chloroprene as a Human CarcinogenSonja N Sax, P Robinan Gentry, Cynthia Van Landingham, et al.
Regulatory Toxicology and Pharmacology : RTP|February 19, 2014
The impact of recent advances in research on arsenic cancer risk assessmentP Robinan Gentry, Harvey J Clewell, Tracy B Greene, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Physiologically based pharmacokinetic/toxicokinetic modelingJerry L Campbell, Rebecca A Clewell, P Robinan Gentry, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 30, 2019
Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk AssessmentHarvey Checkoway, Peter S J Lees, Linda D Dell, et al.
Critical Reviews in Toxicology|August 16, 2011
Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalateP Robinan Gentry, Harvey J Clewell, Rebecca Clewell, et al.
Pageof 5